Premium
ASIC1 Contributes to Store‐Operated Currents in Pulmonary Vascular Smooth Muscle
Author(s) -
Jernigan Nikki L,
Paffett Michael L,
Walker Benjimen R,
Resta Thomas C
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.769.4
Subject(s) - acid sensing ion channel , amiloride , hypoxic pulmonary vasoconstriction , vasoconstriction , cyclopiazonic acid , vascular smooth muscle , patch clamp , chemistry , ion channel , biophysics , medicine , endocrinology , biology , receptor , biochemistry , sodium , smooth muscle , intracellular , organic chemistry
Store‐operated Ca 2+ entry (SOCE) plays a significant role in pulmonary vasoregulatory mechanisms such as hypoxic pulmonary vasoconstriction and receptor‐mediated arterial constriction. Our laboratory has recently suggested that a unique family of non‐selective cation channels, the acid‐sensing ion channel 1 (ASIC1), contributes to SOCE in pulmonary arterial smooth muscle (PASM). To further investigate a role for ASIC1 in SOCE, we hypothesized that ASIC1 contributes to store‐operated Ca 2+ currents in PASM cells. To test this hypothesis we measured cyclopiazonic acid (CPA)‐induced Ca 2+ and Na + currents using conventional whole cell patch‐clamp configuration in voltage‐clamp mode. We found that the ASIC inhibitors, amiloride (30 µM) and benzamil (10 µM), largely attenuated both CPA‐induced Ca 2+ and Na + currents in freshly isolated and primary cultured rat PASM cells. Consistent with these results, we additionally found that ASIC1 siRNA inhibited CPA‐induced Ca 2+ and Na + currents. In contrast, ASIC3 siRNA diminished CPA‐induced Na + currents, but had no effect on Ca 2+ currents, whereas ASIC2 siRNA was without effect on either CPA‐induced Ca 2+ or Na + currents. Together, these data provide further evidence for a novel role of ASIC1 in mediating SOCE in PASM. This work is supported by NIH and AHA.